An Evaluation of Atypical Antipsychotic Use, Costs and Effectiveness in the Pediatric Population
<p> The pediatric mental health burden in the United States (US) is substantial, with more than 4 million children meeting diagnostic criteria for a mental health disorder. As of 2014, this number represented 20% of US children and adolescents. In 2010, mental health disorders are estimated to...
Main Author: | Donovan, Kellye A. |
---|---|
Language: | EN |
Published: |
University of Rhode Island
2018
|
Subjects: | |
Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10748213 |
Similar Items
-
Prevalence of Anti-diabetic and Antilipidemic Medications in Children and Adolescents treated with Atypical Antipsychotics in a Virginia Medicaid Population
by: Varghese, Della
Published: (2013) -
Resource Utilization and Costs Associated with Off-label use of Atypical Antipsychotics in an Adult Population
by: Varghese, Della
Published: (2016) -
Pharmacokinetics of pyronaridine in adult and pediatric populations
by: Ayyoub, Amal Suleiman
Published: (2016) -
Health Outcomes Assessment for Children and Adolescents with Bipolar Disorder Treated with and without Atypical Antipsychotics
by: Jing, Yonghua
Published: (2009) -
Design And Evaluation Of Theophylline Monitoring For Home Health Care Patients
by: Mikhail, May Naim
Published: (1987)